Poston, J. N., Fromm, J. R., Rasmussen, H. A., Shustov, A. R., Libby, E. N., Smith, S. D., . . . Gopal, A. K. (2018). A Pilot Study of Weekly Brentuximab Vedotin in Patients with CD30+ Malignancies Resistant to Brentuximab Vedotin every 3 weeks. Br J Haematol.
Stile di citazione ChicagoPoston, Jacqueline N., Jonathan R. Fromm, Heather A. Rasmussen, Andrei R. Shustov, Edward N. Libby, Stephen D. Smith, Ted Gooley, e Ajay K. Gopal. "A Pilot Study of Weekly Brentuximab Vedotin in Patients With CD30+ Malignancies Resistant to Brentuximab Vedotin Every 3 Weeks." Br J Haematol 2018.
Citazione MLAPoston, Jacqueline N., et al. "A Pilot Study of Weekly Brentuximab Vedotin in Patients With CD30+ Malignancies Resistant to Brentuximab Vedotin Every 3 Weeks." Br J Haematol 2018.